- Home
- PHT
as 07-26-2024 4:00pm EST
Pioneer High Income Trust is a closed-end management investment company. Its investment objective is to provide a high level of current income and to seek capital appreciation. The group generally invests in fixed income markets. Geographically its activities are carried out through the United States.
| Founded: | 2002 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 219.2M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 85.5K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | Monthly | |
| EPS: | 0.98 | EPS Growth: | N/A |
| 52 Week Low/High: | $6.41 - $7.60 | Next Earning Date: | 01-01-0001 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Pioneer High Income Fund Inc. News
PHT Breaking Stock News: Dive into PHT Ticker-Specific Updates for Smart Investing
Business Wire
7 days ago
Amundi US Announces Proposed Transaction Relating to Pioneer Closed-End Funds
Business Wire
23 days ago
Amundi US Declares Monthly Distributions for the Pioneer Closed-End Funds
Newsfile
2 months ago
Edge Total Intelligence Inc. Updates Status of MCTO
CNW Group
2 months ago
Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku
GlobeNewswire
2 months ago
Nokia introduces Network Exposure Platform to expand and simplify network API exposure for service providers
CNW Group
2 months ago
HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA
GlobeNewswire
2 months ago
The sale of Aspo's subsidiary ESL Shipping's Supramax vessels has been completed on June 11 2024
GlobeNewswire
2 months ago
Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY
Compare PHT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PHT Pioneer High Income Fund Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.